These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21341)

  • 21. Effects of prazosin and phenoxybenzamine on alpha- and beta-receptor-mediated responses in intestinal resistance and capacitance vessels.
    Patel P; Bose D; Greenway C
    J Cardiovasc Pharmacol; 1981; 3(5):1050-9. PubMed ID: 6168850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alpha-adrenergic blockade in the treatment of essential hypertension.
    De Leeuw PW; Birkenhäger WH
    Neth J Med; 1983; 26(9):274-82. PubMed ID: 6140644
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction between prazosin and benzodioxan antihypertensives (R 28935 and R 29814); a competition for central alpha 1-adrenoceptors [proceedings].
    Kwa HY; Timmermans PB; Van Zwieten PA
    Br J Pharmacol; 1980 Jan; 68(1):138P-139P. PubMed ID: 6244026
    [No Abstract]   [Full Text] [Related]  

  • 24. Alpha adrenergic blockade by prazosin in therapy of essential hypertension.
    Ram CV; Anderson RJ; Hart GR; Crumpler CP
    Clin Pharmacol Ther; 1981 Jun; 29(6):719-22. PubMed ID: 6112091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha blocking action of the antihypertensive agent, prazosin.
    Graham RM; Oates HF; Stoker LM; Stokes GS
    J Pharmacol Exp Ther; 1977 Jun; 201(3):747-52. PubMed ID: 17000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivatives of 1,3-disubstituted 2,4(1H,3H)-quinazolinediones as possible peripheral vasodilators or antihypertensive agents.
    Havera HJ; Vidrio H
    J Med Chem; 1979 Dec; 22(12):1548-50. PubMed ID: 231656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potent alpha-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments.
    Shibata S; Satake N; Suh TK; Ishida Y; Ueda S; Follmer C; Flores F
    Gen Pharmacol; 1986; 17(2):143-9. PubMed ID: 2870954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic and neuroendocrine responses to acute and chronic alpha-adrenergic blockade with prazosin and phenoxybenzamine.
    Mulvihill-Wilson J; Gaffney FA; Pettinger WA; Blomqvist CG; Anderson S; Graham RM
    Circulation; 1983 Feb; 67(2):383-93. PubMed ID: 6129077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent developments in noradrenergic neurotransmission and its relevance to the mechanism of action of certain antihypertensive agents.
    Langer SZ; Cavero I; Massingham R
    Hypertension; 1980; 2(4):372-82. PubMed ID: 6105128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation between adrenergic neurogenic contraction and alpha 1-adrenoceptor subtypes in dog mesenteric and carotid arteries and rabbit carotid arteries.
    Muramatsu I
    Br J Pharmacol; 1991 Jan; 102(1):210-4. PubMed ID: 1675144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 3-[2-[4-(o-methoxyphenyl)-1-piperazinyl]ethyl]-2,4(1H,3H)- quinazolinedione monophydrochloride (SGB-1534), an antihypertensive agent, on 3H-prazosin and 3H-p-aminoclonidine binding to alpha 1- and alpha 2-adrenoceptors in dog brain and aorta.
    Nagatomo T; Aono J; Tajiri A; Nakamura T; Tsuchihashi H
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):1122-7. PubMed ID: 2900699
    [No Abstract]   [Full Text] [Related]  

  • 32. Complete blockade by phenoxybenzamine of alpha 1- but not of alpha 2-vascular receptors in dogs and the effects of propranolol.
    Constantine JW; Lebel W
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Nov; 314(2):149-56. PubMed ID: 6256667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Support for a role for feedback regulation of norepinephrine release.
    Kirpekar SM
    Fed Proc; 1984 Apr; 43(5):1375-8. PubMed ID: 6142836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
    Yen MH; Sheu JR; Peng IH; Lee YM; Chern JW
    J Pharm Pharmacol; 1996 Jan; 48(1):90-5. PubMed ID: 8722503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postsynaptic alpha-adrenoceptors in the hypertensive rat: studies on vascular reactivity in vivo and receptor binding in vitro.
    Hicks PE; Nahorski SR; Cook N
    Clin Exp Hypertens A; 1983; 5(3):401-27. PubMed ID: 6132689
    [No Abstract]   [Full Text] [Related]  

  • 36. Practical clinical pharmacology of antihypertensive drugs.
    Gifford RW
    Cardiovasc Clin; 1975; 7(1):143-56. PubMed ID: 238740
    [No Abstract]   [Full Text] [Related]  

  • 37. Suppression of reflex tachycardia by central administration of the alpha-1 adrenoceptor antagonists urapidil and prazosin in anesthetized dogs.
    Shebuski RJ; Zimmerman BG
    J Pharmacol Exp Ther; 1985 Aug; 234(2):456-62. PubMed ID: 2862276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of renin secretion by intrarenal alpha-adrenoceptor blockade.
    Blair ML
    Am J Physiol; 1981 Jun; 240(6):E682-8. PubMed ID: 6264792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of alpha-adrenoceptors in the regulation of renal tubular sodium reabsorption and renin secretion in the rabbit.
    Hesse IF; Johns EJ
    Br J Pharmacol; 1985 Mar; 84(3):715-24. PubMed ID: 2859065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin.
    Downing OA; Wilson KA; Wilson VG
    Br J Pharmacol; 1983 Oct; 80(2):315-22. PubMed ID: 6140057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.